Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-23

Clinical Trial Update: Exploratory Study on POL6326 in Stem Cell Mobilization [Phase 2]

View source ↗

Summary

An exploratory Phase 2 trial of POL6326 for stem cell mobilization in Multiple Myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POL6326

Snippet

Sponsor: Polyphor Ltd. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED